Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)

Nina Hasiwa; Mardas Daneshian; Peter Bruegger; Stefan Fennrich; Astrid Hochadel; Sebastian Hoffmann; Felix E. Rivera-Mariani; Christoph Rockel; Stefanie Schindler; Ingo Spreitzer; Sandra Stoppelkamp; Kranthi Vysyaraju; Thomas Hartung

doi:10.14573/altex.1410081

Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)

Nina Hasiwa
, Mardas Daneshian
, Peter Bruegger
, Stefan Fennrich
, Astrid Hochadel
, Sebastian Hoffmann
, Felix E. Rivera-Mariani
, Christoph Rockel
, Stefanie Schindler
, Ingo Spreitzer
, Sandra Stoppelkamp
, Kranthi Vysyaraju
, Thomas Hartung

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Regarding this t⁴ report, which appeared in ALTEX (2013), 30(2), as co-author Thomas Hartung would like to acknowledge that the respective patents referred to, which he holds as the co-inventor of the whole blood pyrogen test, were at the time of the article licensed to Biotest Pharmaceuticals, Germany, and he received royalties from sales of this test. The license and associated royalty payment obligations were in the meantime transferred to Merck-Millipore, France.

Original language	English (US)
Pages (from-to)	499
Number of pages	1
Journal	ALTEX
Volume	31
Issue number	4
DOIs	https://doi.org/10.14573/altex.1410081
State	Published - 2014

ASJC Scopus subject areas

Pharmacology
Medical Laboratory Technology

Access to Document

10.14573/altex.1410081

Cite this

Hasiwa, N., Daneshian, M., Bruegger, P., Fennrich, S., Hochadel, A., Hoffmann, S., Rivera-Mariani, F. E., Rockel, C., Schindler, S., Spreitzer, I., Stoppelkamp, S., Vysyaraju, K., & Hartung, T. (2014). Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2). ALTEX, 31(4), 499. https://doi.org/10.14573/altex.1410081

Hasiwa, N, Daneshian, M, Bruegger, P, Fennrich, S, Hochadel, A, Hoffmann, S, Rivera-Mariani, FE, Rockel, C, Schindler, S, Spreitzer, I, Stoppelkamp, S, Vysyaraju, K & Hartung, T 2014, 'Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)', ALTEX, vol. 31, no. 4, pp. 499. https://doi.org/10.14573/altex.1410081

@article{fee02d1941be49a3b53b3266bd9c85b2,

title = "Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)",

abstract = "Regarding this t4 report, which appeared in ALTEX (2013), 30(2), as co-author Thomas Hartung would like to acknowledge that the respective patents referred to, which he holds as the co-inventor of the whole blood pyrogen test, were at the time of the article licensed to Biotest Pharmaceuticals, Germany, and he received royalties from sales of this test. The license and associated royalty payment obligations were in the meantime transferred to Merck-Millipore, France.",

author = "Nina Hasiwa and Mardas Daneshian and Peter Bruegger and Stefan Fennrich and Astrid Hochadel and Sebastian Hoffmann and Rivera-Mariani, \{Felix E.\} and Christoph Rockel and Stefanie Schindler and Ingo Spreitzer and Sandra Stoppelkamp and Kranthi Vysyaraju and Thomas Hartung",

year = "2014",

doi = "10.14573/altex.1410081",

language = "English (US)",

volume = "31",

pages = "499",

journal = "ALTEX",

issn = "1868-596X",

publisher = "ALTEX Edition",

number = "4",

}

TY - JOUR

T1 - Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30

T2 - 2)

AU - Hasiwa, Nina

AU - Daneshian, Mardas

AU - Bruegger, Peter

AU - Fennrich, Stefan

AU - Hochadel, Astrid

AU - Hoffmann, Sebastian

AU - Rivera-Mariani, Felix E.

AU - Rockel, Christoph

AU - Schindler, Stefanie

AU - Spreitzer, Ingo

AU - Stoppelkamp, Sandra

AU - Vysyaraju, Kranthi

AU - Hartung, Thomas

PY - 2014

Y1 - 2014

N2 - Regarding this t4 report, which appeared in ALTEX (2013), 30(2), as co-author Thomas Hartung would like to acknowledge that the respective patents referred to, which he holds as the co-inventor of the whole blood pyrogen test, were at the time of the article licensed to Biotest Pharmaceuticals, Germany, and he received royalties from sales of this test. The license and associated royalty payment obligations were in the meantime transferred to Merck-Millipore, France.

AB - Regarding this t4 report, which appeared in ALTEX (2013), 30(2), as co-author Thomas Hartung would like to acknowledge that the respective patents referred to, which he holds as the co-inventor of the whole blood pyrogen test, were at the time of the article licensed to Biotest Pharmaceuticals, Germany, and he received royalties from sales of this test. The license and associated royalty payment obligations were in the meantime transferred to Merck-Millipore, France.

UR - https://www.scopus.com/pages/publications/84989916474

UR - https://www.scopus.com/pages/publications/84989916474#tab=citedBy

U2 - 10.14573/altex.1410081

DO - 10.14573/altex.1410081

M3 - Comment/debate

AN - SCOPUS:84989916474

SN - 1868-596X

VL - 31

SP - 499

JO - ALTEX

JF - ALTEX

IS - 4

ER -

Addendum to evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test (ALTEX (2013) 30: 2)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this